To date, the primary approach to improve the transfection properties of cationic lipids has been the synthesis of new kinds of cationic amphipaths or the inclusion of noncationic helper lipids. Here, it is reported that an alternative approach can be unusually effective, namely, the combination of two cationic lipid derivatives having the same head group but tails of different chain lengths. Particularly efficient was the combination of dilauroyl (12 carbon chain) and dioleoyl (18 carbon chain) homologues of O-ethylphosphatidylcholine.
Cationic lipids have been widely used for the delivery of plasmid and antisense DNA into eucaryotic cells; however, inefficiency of transfection is a major problem confronting their use in gene therapy. Vascular endothelial cells act as an interface between circulating blood and various tissues and organs of the body, and are known to be involved in inflammatory processes such as leukocyte recruitment, cytokine production, [1] [2] [3] and to play a major role in the pathogenesis of atherosclerosis, [4] [5] as well as angiogenesis, [6] [7] [8] [9] on which the growth and spread of tumors are dependent. Hence, they are of considerable interest as a gene therapy target. [10] [11] Even though they are readily accessible, gene therapy with nonviral vectors of endothelial tissue has been seriously hampered by the fact that endothelial cells are very difficult to transfect. According to Teifel et al, 12 the transfection efficiency of vascular endothelial cells with cationic lipids was only 2%. In our experience, the cytotoxicity of cationic lipids increases with the shortening of acyl groups and so cationic lipids used in transfection invariably have alkyl chains that are 14 or more carbon long. Here, we report that a medium-chain cationic phosphocholine (1,2-dilauroyl-sn-glycero-3-ethylphosphocholine, EDLPC), when combined with longer chain compounds (1,2-dioleoyl-sn-glycero-3-ethylphosphocholine, EDOPC, or 1,2-dimyristol-sn-glycero-3-ethylphosphocholine, EDM-PC), dramatically enhances (up to 30-fold) the transfection of human umbilical artery endothelial cells (HUAEC) even though, individually, EDLPC, EDOPC, or EDMPC are quite weak transfection reagents. Moreover, transfection can be adjusted to be optimal either in the presence or absence of serum by changing the EDLPC/EDOPC ratio and the ratio of total lipids to DNA, and under optimal conditions, transfection efficiency up to 15% can be achieved both in the presence and absence of serum. Thus, these formulations constitute a novel form of cellular transfection reagent and offer entirely new formulation possibilities for optimizing in vivo gene delivery. At present, only phosphatidylethanolamine and cholesterol are used as the helper lipids to improve the transfection properties of cationic lipids. This is the first report, as far as we know, on the use of a combination of compounds with different chain lengths but the same head group to improve the gene delivery properties of lipoplexes. Figure 1 shows that combining EDLPC (Avanti Polar Lipids, Inc., Alabaster, AL, USA) with EDOPC (synthesized in our lab according to MacDonald et al 13 ) enhances by B30-fold the extent of transfection of HUAEC (BioWhitakker, Inc., Walkersville, MD, USA), compared with EDLPC or EDOPC alone. The ratio of EDLPC to EDOPC is important and different ratios are optimal, depending upon whether serum is present or absent. The EDLPC/EDMPC (EDMPC was synthesized in our lab according to MacDonald et al 13 ) mixture exhibits a similar pattern to that of EDLPC/EDOPC, but the extent of transfection is lower than that of EDLPC/EDOPC.
On the basis of the results presented above, EDLPC/ EDOPC (80/20) and EDLPC/EDOPC (60/40) were chosen to further optimize transfection; the ratio of lipids to DNA and the amount of DNA were used as optimization parameters. Figure 2 depicts the change of transfection with the ratio of EDLPC to EDOPC and the ratio of total lipids to DNA. What is particularly interesting is that for some formulations, transfection without serum was better than that in serum; but for others, transfection in serum was better than that in the absence of serum. The highest transfection in the absence of serum was obtained when EDLPC/EDOPC ¼ 80/20 and lipid/DNA ¼ 4/1 (termed 80/20/25 (EDLPC/ EDOPC/DNA), and the molecular ratio is 47/8/31), with 0.5 mg DNA/well; under these conditions, the extent of expression was 8 Â higher than that in the presence of serum. In contrast, the most efficient transfection in the presence of serum was when EDLPC/EDOPC ¼ 60/40 and lipid/DNA ¼ 6/1 (termed 60/40/16.7 (EDLPC/EDOPC/DNA), and the molecular ratio is 52/25/31), with 1.0 mg DNA/well, under which condition the expression was 20 Â that in the absence of serum. According to X-gal staining, 15% of the cells treated under both of these conditions were positive. These two formulations were thus used in subsequent studies.
Some of the treatment conditions corresponded to rather significant toxicity (as determined using the MTT method); however, in general, there was no discernable relationship between extent of transfection and cell viability. It might be expected that the extent of tranfection would decrease with decreasing viability, but that behavior was apparent only in the case of the absence of serum for EDLPC/EDOPC ¼ 60/40 and lipid/DNA ¼ 4/1.
These data raise two questions: why was there such a large difference between the extents of transfection by Figure 1 Extent of transfection of HUAEC varies with the ratio of medium-chain to long-chain lipids. The cells were seeded in 96-well plates at 24 h before transfection at densities to give about 80% confluence at the time of transfection. Chloroform solutions of EDLPC and EDOPC were mixed at the different ratios and then the chloroform was removed under an N 2 stream and high vacuum. The lipid mixtures were hydrated in HBSS (HEPES-buffered saline solution) at 1 mg/ml to form liposomes. Liposomes and plasmid DNA (b-galactosidase, purchased from Clontech Labtories Inc., Palo Alto, CA, USA and propagated and purified by Bayou Biolabs, Harahan, LA, USA) were diluted in OptiMEM to 80 mg/ml for lipid and to 20 mg/ml for DNA, and liposomes were pipetted into an equal volume of plasmid DNA solution at a 4:1 weight ratio and mixed gently. The resultant DNA-lipid complexes were incubated at room temperature for 15 min and then 50 ml/well (1 mg DNA/well) was added to the cells that were either in medium lacking serum (black bars) or medium containing 5% serum (gray bars). At 2 h after addition of DNA-lipid complexes, the cells were washed with HBSS and fresh complete medium was added. Cells were assayed for b-galactosidase activity 24 h after transfection with a microplate fluorometric assay. Data represent the mean7s.d. of a representative experiment performed in quadruplicate. In all, B20 000 fluorescence units correspond to approximately 0.1 milliunit of bgalactosidase. Transfection with medium-chain/long-chain cationic lipids L Wang and RC MacDonald these two formulations in the presence of serum? Why does the incorporation of a particular proportion of EDLPC cause such a large change in transfection efficiency? One possible answer to these questions is that the medium-chain lipid facilitates mixing of the lipoplex lipid with cellular lipid, which could lead to the neutralizing of the positive charge of the cationic lipid and facilitate release of DNA from the complex. 14, 15 If that were the case, one might expect EDLPC to facilitate fusion (or at least lipid mixing) of cationic liposomes with anionic liposomes. We therefore compared the fusion of EDLPC/EDOPC (80/20/15), EDLPC/EDOPC (60/40/16.7), and pure EDOPC lipoplexes with phosphatidylglycerol-containing (anionic) liposomes. Membrane fusion was measured using a FRET assay 16 that measures reduction of energy transfer between NBD-PE and Rh-PE in cationic lipids of the lipoplexes as they fuse with egg PC liposomes containing 20% DOPG (Avanti Polar Lipids, Inc., Alabaster, AL, USA). From Figure 3 , it is seen that the extent of fusion of EDLPC/EDOPC (80/ 20/25) and EDLPC/EDOPC (60/40/16.7) lipoplexes is significantly higher than that of pure EDOPC.
In order to determine if this pattern of fusion obtains within cells -that is, that the mixture is more prone to fuse with endosomal membranes so that more DNA can escape from endosomal degradation and hence enter nuclei -the intracellular distribution of fluorescent lipid and oligonucleotide in EDOPC and EDLPC/EDOPC (60/40/16.7) lipoplexes was investigated. These experiments were particularly dramatic because of the availability of highly fluorescent oligonucleotides and the relatively low barrier to entry of oligonucleotides into the nucleus. Since escape of lipoplexes from endosomes prior to their entry into lysosomes is essential for efficient trangene expression, fusion of lipoplexes with endosomal membranes should facilitate DNA release from endosomes into the cytoplasm, and thus increase DNA expression. This may be one reason that transfection by the mixtures of lipids is much higher than that of pure EDOPC. However, this does not explain the difference in transfection efficiency between the two mixtures under serum/no-serum condition.
Serum strongly influences properties of lipoplexes, so we also examined the effect of serum on the composition of the two chosen formulations. Lipoplexes were treated with 5% serum at 371C for 30 min, and then centrifuged at 14 000 rpm (41C) for 1 h. The pellets were collected and extracted with chloroform. The chloroform phase was applied to a TLC plate, which was then developed in chloroform/methanol/H 2 O (65/25/4). The separated EDLPC and EDOPC were obtained by extracting the SiO 2 of the relevant regions of the TLC plate with chloroform/methanol/H 2 O (10/10/1). EDLPC and EDOPC were quantified with a standard phosphate assay. It was found that, after 30 min incubation in serum, for EDLPC/EDOPC (60/40/16.7), 10% of the EDOPC and EDLPC were extracted from the lipoplexes; in the case of EDLPC/EDOPC (80/20/25), 20% of the EDOPC and 35% of the EDLPC was extracted. Since extraction time was rather long compared to uptake of lipoplexes by cells, these estimates of lipid extraction certainly represent an upper limit.
Finally, gene expression in delipidated serum (Cocalico Biologicals, Inc., Reamstown, PA, USA) was tested ( Figure 5 ) to assess the possible effect of lipid extraction into serum. Transgene expression of both formulations decreased significantly in delipidated serum, in which B80% lipids (including cholesterol, HDL cholesterol, LDL cholesterol, and phospholipids, according to data from the supplier) are absent relative to normal serum. Since delipidated serum, with a higher lipid binding capacity than normal serum, would also extract more lipids from the lipoplexes, these results are consistent with those based on direct analysis of lipid loss in serum. It thus seems likely that the different optimal compositions for transfection in the presence and absence of serum are due to the fact that some lipid mixtures are more susceptible to change of composition in serum than are others. This is perhaps not surprising, since others have shown that shorter alkyl chain lipids are characterized by an increased rate of spontaneous transfer to lipoproteins and plasma membrane. 17, 18 In conclusion, the inclusion of EDLPC in EDOPC lipoplexes increases their rate and extent of membrane fusion (measured as lipid mixing) with anionic liposomes ( Figure 3) . Intracellularly, EDLPC facilitates fusion of lipoplexes with endosomal membranes and induces oligonucleotide release from endosomes into the cytoplasm, allowing entry into nuclei (Figure 4 ). This effect is particularly obvious with oligonucleotides, and is much less so with plasmid DNA; however, larger DNAs also are probably more completely released from lipoplexes Figure 3 Membrane fusion of fluorescence-labeled, cationic lipoplexes with anionic liposomes. The lipids were labeled with 0.5 mol% each of NBD-PE and Rh-PE and hydrated at 1 mg/ml in PBS. Lipoplexes were then prepared as for transfection. In total, 200 ml of the resulting lipoplex dispersion was titrated with a three-fold molar excess of unlabeled egg PC liposomes containing 20% DOPG. The experiments were carried out at 371C. Ex ¼ 320 nm, Em ¼ 535 nm. % membrane fusion ¼ (F n ÀF 0 )/ (F 100 ÀF 0 ) Â 100%, where F n is the fluorescence after the addition of anionic lipid, F 0 is the initial fluorescence of lipoplexes, and F 100 is the fluorescence when anionic lipid was mixed directly with cationic lipids in chloroform and then lipoplexes were prepared as above.
Transfection with medium-chain/long-chain cationic lipids L Wang and RC MacDonald that contain medium-chain cationic lipids. Increased DNA release from lipoplexes that contain medium-chain lipids is likely to be related to fusion of lipoplex lipid with cellular lipid, leading to dilution or neutralization and facilitating release of the DNA. These advantages of medium-chain molecules are not without a disadvantage; however, for EDLPC is more toxic than EDOPC. It thus appears that a balance must be struck between easy lipid fusion and toxicity, and formulations containing mixed medium-and long-chain cationic lipids allow such a balance to be obtained. Serum has effects on transfection and its influence varies with the composition of lipoplexes. More lipids are extracted by serum from 80/20/25 than from 60/40/ 16.7 lipoplexes, with the result that the latter yield higher transfection in the presence of serum than do the former. Thus, while EDLPC improves the fusion property of lipoplexes, EDOPC increases the serum stability of lipoplexes, and a different optimal initial composition is found in the presence than in the absence of serum.
Since the properties of mixed lipid lipoplexes can be tuned by changing the ratio of medium-chain to longchain cationic lipids and the ratio of lipid to DNA according to experimental conditions, medium-chain/ long-chain cationic lipid mixtures may constitute a new approach to more efficient transfection reagents. The mechanisms underlying the effect need further study and are currently under investigation. Transfection with medium-chain/long-chain cationic lipids L Wang and RC MacDonald
